• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[局部注射OK-432/纤维蛋白原/凝血酶治疗不可切除的转移性肝癌]

[Locoregional injection of OK-432/fibrinogen/thrombin for unresectable metastatic liver tumors].

作者信息

Yoshida T, Osato H, Sakon M, Monden T, Amano M, Aoki T, Kishimoto S, Umeshita K, Dono K, Gotoh M, Monden M

机构信息

Dept. of Surgery II, Osaka University Medical School.

出版信息

Gan To Kagaku Ryoho. 1996 Sep;23(11):1575-7.

PMID:8854809
Abstract

We performed the locoregional injection of OK-432/fibrinogen/thrombin to unresectable hepatic tumors metastasized from colorectal cancers, which were hardly controlled by arterial infusion chemotherapy. CEA was markedly decreased following this treatment, although abdominal CT did not show a significant reduction of tumor mass. This immuno-injection therapy may be a choice of treatment for metastatic liver tumors, refractory to treatment by conventional chemotherapy.

摘要

我们对无法切除的、由结直肠癌转移而来且难以通过动脉灌注化疗控制的肝肿瘤进行了局部区域注射OK-432/纤维蛋白原/凝血酶治疗。尽管腹部CT显示肿瘤体积无明显缩小,但治疗后癌胚抗原显著降低。这种免疫注射疗法可能是传统化疗难治性转移性肝肿瘤的一种治疗选择。

相似文献

1
[Locoregional injection of OK-432/fibrinogen/thrombin for unresectable metastatic liver tumors].[局部注射OK-432/纤维蛋白原/凝血酶治疗不可切除的转移性肝癌]
Gan To Kagaku Ryoho. 1996 Sep;23(11):1575-7.
2
[A patient with unresectable cancer of pancreas head, effectively treated by a local injection of the mixture of OK-432, fibrinogen and thrombin].
Gan To Kagaku Ryoho. 1996 Sep;23(11):1621-3.
3
[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].[环磷酰胺、大剂量溶链菌制剂与重组白细胞介素-2序贯免疫疗法对伴有弥漫性转移性肝肿瘤的乳腺癌患者的治疗效果改善]
Nihon Geka Gakkai Zasshi. 1991 Jan;92(1):64-74.
4
[The efficacy of transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].[经动脉免疫栓塞疗法治疗肝细胞癌患者的疗效]
Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1437-40.
5
Role of urokinase-type plasminogen activator in local immunotherapy.尿激酶型纤溶酶原激活剂在局部免疫治疗中的作用。
Oncol Rep. 1998 Mar-Apr;5(2):329-33.
6
[Transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].肝细胞癌患者的经动脉免疫栓塞治疗
Gan To Kagaku Ryoho. 1997 Sep;24(12):1665-7.
7
[Efficacy of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma].经动脉免疫栓塞疗法(TIE)对可手术切除的肝细胞癌患者的疗效
Gan To Kagaku Ryoho. 1993 Aug;20(11):1465-8.
8
[Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer].
Gan To Kagaku Ryoho. 1998 Jul;25(9):1397-401.
9
[Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy].[可降解淀粉微球联合阿霉素、丝裂霉素C肝动脉灌注治疗结直肠癌肝转移的疗效观察——治疗早期CEA变化分析]
Gan To Kagaku Ryoho. 2003 Oct;30(11):1686-8.
10
Hepatic arterial infusion chemotherapy combined with hyperthermia for metastatic liver tumors of colorectal cancer.
Semin Oncol. 1997 Apr;24(2 Suppl 6):S6-135-S6-138.